5-Isopropyl-3-phenyl-2-thioxoimidazolidin-4-one

Catalog No.: 
ACSUKH603
CAS No.: 
4333-20-4
Molecular Formula: 
C12H14N2OS
Molecular Weight: 
234.32
5-Isopropyl-3-phenyl-2-thioxoimidazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$54.00In stockInquiry
5g98%$248.00In stockInquiry
25g98%$982.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Isopropyl-3-phenyl-2-thioxoimidazolidin-4-one
IUPAC Name5-isopropyl-3-phenyl-2-thioxoimidazolidin-4-one
MDL No.MFCD06858300
Molecular FormulaC12H14N2OS
Molecular Weight234.32
SMILESO=C(C(C(C)C)N1)N(C2=CC=CC=C2)C1=S
InChI KeyHEIKHJHSVLQGGN-UHFFFAOYSA-N
Synonym4-Imidazolidinone, 5-(1-methylethyl)-3-phenyl-2-thioxo- | CS-0311791 | 3-phenyl-5-propan-2-yl-2-sulfanylideneimidazolidin-4-one | P0379 | 3-Phenyl-5-(propan-2-yl)-2-sulfanyl-3,5-dihydro-4H-imidazol-4-one | Valine 3-phenyl-2-thiohydantoin | HEIKHJHSVLQGGN-
CAS No.4333-20-4
PubChem CID2831422

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACSUKH603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSUKH603 route product structure diagram
    ACSUKH6034333-20-4In Stock
Inquiry

2. ACSUKH603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSUKH603 route product structure diagram
    ACSUKH6034333-20-4In Stock
Inquiry

3. ACSUKH603 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSUKH603 route product structure diagram
    ACSUKH6034333-20-4In Stock
Inquiry

Comments (0)